Update on Clinical Trials of Antiplatelet Therapy for Cerebrovascular Diseases

Publisher： Karger

E-ISSN： 1421-9786|10|5|34-40

ISSN： 1015-9770

Source： Cerebrovascular Diseases, Vol.10, Iss.5, 2004-11, pp. : 34-40

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Clinical Perspectives on the Role of Anti-Platelet and Statin Therapy in Patients with Vascular Diseases

By  

Current Vascular Pharmacology, Vol. 1, Iss. 3, 2003-10 ,pp. : 329-333

Bentham Science Publishers

Access to resources Recommend Favorite

Efficacy of Dual Antiplatelet Therapy in Cerebrovascular Disease as Demonstrated by a Decline in Microembolic Signals

By  

Cerebrovascular Diseases, Vol. 21, Iss. 4, 2006-03 ,pp. : 242-246

Karger

Access to resources Recommend Favorite

Clinical Trials in Hepatocellular Carcinoma: An Update

By  

Liver Cancer, Vol. 2, Iss. 3-4, 2013-08 ,pp. : 345-364

Karger

Access to resources Recommend Favorite

Usefulness of Antiplatelet Drugs in Ischaemic Stroke Prevention – Update on New Trials

By  

Cerebrovascular Diseases, Vol. 24, Iss. 1, 2007-11 ,pp. : 112-115

Karger

Access to resources Recommend Favorite

Current Problems, New Opportunities and Future Directions of Antiplatelet Therapy - Increasing Role of Novel Antiplatelet Agents in Cardiovascular Diseases

By  

Recent Patents on Cardiovascular Drug Discovery, Vol. 4, Iss. 1, 2009-01 ,pp. : 55-60

Bentham Science Publishers

Access to resources Recommend Favorite